Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cholecystokinin in anxiety

H J van Megen1, H G Westenberg, J A den Boer

  • 1Rudolf Magnus Institute for Neurosciences, Department of Psychiatry, University Hospital Utrecht, Netherlands.

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|November 1, 1996
PubMed
Summary

Cholecystokinin (CCK), a key neuropeptide in the brain, interacts with GABA and serotonin. CCK4 tests suggest it triggers panic, and CCKB antagonists may reduce anxiety in humans.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ovariectomy-induced depressive-like behavior and brain glucose metabolism changes in female rats are not affected by chronic mild stress.

Psychoneuroendocrinology·2020
Same author

Serotonergic compounds in panic disorder, obsessive-compulsive disorder and anxious depression: A concise review.

Human psychopharmacology·2018
Same author

Longitudinal changes in glucocorticoid receptor exon 1<sub>F</sub> methylation and psychopathology after military deployment.

Translational psychiatry·2017
Same author

Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia.

Translational psychiatry·2017
Same author

Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium.

Psychological medicine·2017
Same author

Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group.

Molecular psychiatry·2017

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Cholecystokinin (CCK) is a significant neuropeptide in the central nervous system (CNS) and gastrointestinal tract.
  • CCK is recognized as the most abundant neuropeptide within the CNS.
  • This review focuses on the CCK neuronal system and its interplay with neurotransmitters like GABA and serotonin (5-HT).

Purpose of the Study:

  • To review the CCK neuronal system and its interactions with GABA and serotonin.
  • To discuss the role of CCK in anxiety, drawing from animal and human studies.
  • To evaluate the CCK4 challenge test as a panicogenic agent and the potential of CCKB antagonists as anxiolytics.

Main Methods:

  • Literature review of the CCK neuronal system.
  • Analysis of animal data regarding CCK and anxiety.

Related Experiment Videos

  • Examination of studies on healthy volunteers and panic disorder patients using CCK4 challenge tests.

    • Main Results:

    • The CCK neuronal system interacts significantly with GABA and serotonin.
    • The CCK4 challenge test demonstrates properties of an ideal panicogenic agent.
    • Evidence suggests CCKB receptor antagonists may offer anxiolytic effects in humans.

    Conclusions:

    • CCK plays a crucial role in CNS functions, including anxiety regulation.
    • The CCK4 challenge test is a valuable tool for studying panic mechanisms.
    • CCKB receptor antagonists represent a promising therapeutic avenue for anxiety disorders.